These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35905842)

  • 1. Nano-drug delivery system with enhanced tumour penetration and layered anti-tumour efficacy.
    Zhang N; Feng N; Xin X; Zhang J; Wu D; Jiang Q; Yu T; Gao M; Zhao S; Yang H; Tian Q
    Nanomedicine; 2022 Sep; 45():102592. PubMed ID: 35905842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid pH-responsive self-disintegrating nanoassemblies balance tumor accumulation and penetration for enhanced anti-breast cancer therapy.
    Li J; Wang Y; Xu C; Yu Q; Wang X; Xie H; Tian L; Qiu Y; Guo R; Lu Z; Li M; He Q
    Acta Biomater; 2021 Oct; 134():546-558. PubMed ID: 33882357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Morph Nanoparticles for Deep Tumor Penetration via Caveolae-Mediated Transcytosis.
    Zhang Z; Wang T; Yang R; Fu S; Guan L; Hou T; Mu W; Pang X; Liang S; Liu Y; Zhang N
    ACS Appl Mater Interfaces; 2020 Aug; 12(34):38499-38511. PubMed ID: 32805954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining Fruquintinib and Doxorubicin in Size-Converted Nano-Drug Carriers for Tumor Therapy.
    Zhang N; Xin X; Feng N; Wu D; Zhang J; Yu T; Jiang Q; Gao M; Yang H; Zhao S; Tian Q; Zhang Z
    ACS Biomater Sci Eng; 2022 May; 8(5):1907-1920. PubMed ID: 35482571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Microenvironment Stimuli-Responsive Nanoparticles for Programmed Anticancer Drug Delivery.
    Jia N; Li W; Liu D; Wu S; Song B; Ma J; Chen D; Hu H
    Mol Pharm; 2020 May; 17(5):1516-1526. PubMed ID: 32243181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
    Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
    Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel, nano-sized, liposome-encapsulated polyamidoamine dendrimer derivatives facilitate tumour targeting by overcoming the polyethylene glycol dilemma and integrin saturation obstacle.
    Li G; Song YZ; Huang ZJ; Chen K; Chen DW; Deng YH
    J Drug Target; 2017 Sep; 25(8):734-746. PubMed ID: 28452577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Dual pH-Responsive DOX-Encapsulated Liposome Combined with Glucose Administration Enhanced Therapeutic Efficacy of Chemotherapy for Cancer.
    Zhai L; Luo C; Gao H; Du S; Shi J; Wang F
    Int J Nanomedicine; 2021; 16():3185-3199. PubMed ID: 34007173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
    Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
    Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smart Superstructures with Ultrahigh pH-Sensitivity for Targeting Acidic Tumor Microenvironment: Instantaneous Size Switching and Improved Tumor Penetration.
    Li HJ; Du JZ; Liu J; Du XJ; Shen S; Zhu YH; Wang X; Ye X; Nie S; Wang J
    ACS Nano; 2016 Jul; 10(7):6753-61. PubMed ID: 27244096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hierarchically stimuli-responsive nanovectors for improved tumor penetration and programed tumor therapy.
    Liu J; Guo X; Luo Z; Zhang J; Li M; Cai K
    Nanoscale; 2018 Jul; 10(28):13737-13750. PubMed ID: 29992216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
    Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
    Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.
    Qiu X; Cao K; Lin T; Chen W; Yuan A; Wu J; Hu Y; Guo H
    Int J Nanomedicine; 2017; 12():7365-7374. PubMed ID: 29066888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of a multifunctional gold-doxorubicin nanoparticle system for pH triggered intracellular anticancer drug release.
    Khutale GV; Casey A
    Eur J Pharm Biopharm; 2017 Oct; 119():372-380. PubMed ID: 28736333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-administration of a charge-conversional dendrimer enhances antitumor efficacy of conventional chemotherapy.
    Cao J; Wang C; Guo L; Xiao Z; Liu K; Yan H
    Eur J Pharm Biopharm; 2018 Jun; 127():371-377. PubMed ID: 29499301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core-shell tecto dendrimers formed via host-guest supramolecular assembly as pH-responsive intelligent carriers for enhanced anticancer drug delivery.
    Wang J; Li D; Fan Y; Shi M; Yang Y; Wang L; Peng Y; Shen M; Shi X
    Nanoscale; 2019 Nov; 11(46):22343-22350. PubMed ID: 31728477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A positron emission tomography image-guidable unimolecular micelle nanoplatform for cancer theranostic applications.
    Yang J; Lu W; Xiao J; Zong Q; Xu H; Yin Y; Hong H; Xu W
    Acta Biomater; 2018 Oct; 79():306-316. PubMed ID: 30172067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
    Han L; Huang R; Liu S; Huang S; Jiang C
    Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH/enzyme dual sensitive and nucleus-targeting dendrimer nanoparticles to enhance the antitumour activity of doxorubicin.
    Wu ZY; Shen JM; Lang H; Yue T; Sun C
    Pharm Dev Technol; 2022 Mar; 27(3):357-371. PubMed ID: 35350969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.